/ EN
2026-03-09 00:00 China Clinical Launch & Registration Translated from EN

Chinese Trial to Test Immediate Neural Effects of Non-Invasive BMI in Stroke

Summary A Chinese trial will measure the immediate effects of a non-invasive brain-machine interface combined with multimodal training on neurophysiological function in patients with upper-limb hemiparesis after stroke. It was registered with the Chinese Clinical Trial Registry as ChiCTR2600120046 on March 9, 2026 and has not begun recruiting.
Why it matters Rehabilitation trials usually report gains only after weeks of training, which leaves open whether the interface or the repetition is doing the work; measuring neurophysiological change immediately after a single session is a cleaner and much cheaper test of mechanism.

BCIwiki (bciwiki.com) — A clinical trial registered at the Chinese Clinical Trial Registry (ChiCTR) on March 9, 2026, under identifier ChiCTR2600120046, will evaluate the immediate effects of a non-invasive brain-machine interface (BMI) combined with multimodal training on neurophysiological functions in patients with upper limb hemiparesis following a stroke. The trial is not yet recruiting.

According to the ChiCTR record republished by the WHO International Clinical Trials Registry Platform (ICTRP), details on trial design, sample size, and sponsor have not been disclosed in the registration. Non-invasive BMI uses scalp electrodes to capture brain signals, enabling patients to drive external devices through motor imagery; multimodal training typically combines multiple sensory and motor feedback modalities to enhance neuroplasticity. This trial focuses on immediate neurophysiological changes after training, rather than long-term functional recovery.

Compiled by BCIwiki from public sources

Sources · 1
Read original ↗
Suggest a correction Revisions · none / EN
© 2026 BCIwiki.com Digest Topics Tips Subscribe Revisions About